| Cellular and molecular mechanisms of HGF/Met in the cardiovascular system S Gallo, V Sala, S Gatti, T Crepaldi Clinical science 129 (12), 1173-1193, 2015 | 152 | 2015 |
| Agonist antibodies activating the Met receptor protect cardiomyoblasts from cobalt chloride-induced apoptosis and autophagy S Gallo, S Gatti, V Sala, R Albano, P Costelli, E Casanova, PM Comoglio, ... Cell death & disease 5 (4), e1185-e1185, 2014 | 75 | 2014 |
| Signaling to cardiac hypertrophy: insights from human and mouse RASopathies V Sala, S Gallo, C Leo, S Gatti, BD Gelb, T Crepaldi Molecular medicine 18, 938-947, 2012 | 53 | 2012 |
| MicroRNAs in myocardial ischemia: identifying new targets and tools for treating heart disease. New frontiers for miR-medicine V Sala, S Bergerone, S Gatti, S Gallo, A Ponzetto, C Ponzetto, T Crepaldi Cellular and molecular life sciences 71, 1439-1452, 2014 | 48 | 2014 |
| HGF/Met axis in heart function and cardioprotection S Gallo, V Sala, S Gatti, T Crepaldi Biomedicines 2 (4), 247-262, 2014 | 46 | 2014 |
| Gene expression profiling of HGF/Met activation in neonatal mouse heart S Gatti, C Leo, S Gallo, V Sala, E Bucci, M Natale, D Cantarella, E Medico, ... Transgenic research 22, 579-593, 2013 | 17 | 2013 |
| Cardiac concentric hypertrophy promoted by activated Met receptor is mitigated in vivo by inhibition of Erk1, 2 signalling with Pimasertib V Sala, S Gallo, S Gatti, E Medico, E Vigna, D Cantarella, L Fontani, ... Journal of molecular and cellular cardiology 93, 84-97, 2016 | 14 | 2016 |
| A mouse model for spatial and temporal expression of HGF in the heart I Riess, V Sala, C Leo, M Demaria, S Gatti, S Gallo, A Fitou, O Boero, ... Transgenic research 20, 1203-1216, 2011 | 11 | 2011 |
| HGF/Met axis has anti-apoptotic and anti-autophagic function in hypoxic cardiac injury S Gallo, S Gatti, V Sala, PM Comoglio, T Crepaldi Receptors & Clinical Investigation 1, 2014 | 4 | 2014 |
| Anti-Differentiation Effect of Oncogenic Met Receptor in Terminally-Differentiated Myotubes V Sala, S Gallo, S Gatti, E Vigna, A Ponzetto, T Crepaldi Biomedicines 3 (1), 124-137, 2015 | 3 | 2015 |
| Met activation for cardioprotection against anthracycline cardiotoxicity. S Gallo, S Gatti, A Bonzano, R Albano, V Sala, P Comoglio, T Crepaldi Vascular Pharmacology 75, 56-56, 2015 | | 2015 |
| Mek1 inhibition in vivo mitigates progressive cardiac concentric hypertrophy promoted by activated Met receptor. V Sala, S Gallo, S Gatti, E Medico, E Vigna, D Cantarella, L Fontani, ... Vascular Pharmacology 75, 47-47, 2015 | | 2015 |
| New mouse models to study HGF/Met role in postnatal heart development and heart disease pathogenesis V Sala, C Leo, S Gallo, S Gatti, M Morello, A Chiribiri, E Bucci, E Medico, ... THE FEBS JOURNAL 278, 477-477, 2011 | | 2011 |
| HGF-mediated modulation of Connexin 43 in cardiac cells S Gallo, C Leo, V Sala, S Gatti, T Crepaldi THE FEBS JOURNAL 278, 284-284, 2011 | | 2011 |
Simona GalloPhd Student, University of TurinVerified email at unito.it
